Evaluation of GenDx protocol for HLA NGS genotyping using the Ion Torrent sequencing platform
DOI:
https://doi.org/10.2478/AMB-2023-0024Keywords:
NGS, HLA alleles, validation, hematopoietic stem cell transplantation, solid organ transplantation, Bone Marrow Donors RegistryAbstract
Background: The Human Major Histocompatibility Complex (HLA) is the most polymorphic region of the human genome and encodes molecules with a central role in antigen-specifi c immune responses. Class I and class II HLA genes have an important role in bone marrow and solid organ transplantations. HLA typing by Next Generation Sequencing (NGS) provides unambiguous second fi eld or allelic level resolution and, therefore, better matching of donor and recipient and a higher chance of survival for transplanted patients. The aim of this study was to validate GenDx NGS HLA typing protocol for 6 HLA loci (HLA-A, -B, -C, DRB1, -DQB1 and DPB1).
Materials and methods: 240 samples of both bone marrow healthy donors from the Bulgarian Bone Marrow Donors Registry (BBMDR) and bone marrow recipients were sequenced on the Ion Torrent System using the GenDx NGS HLA typing kit, compared to 65 samples from the BBMDR analyzed by Holotype HLA kit (Omixon) and sequenced on the Illumina platform MiniSeq.
A number of metrics including allele balance, read length, mappability, coverage and ambiguity were assessed in order to evaluate the GenDx NGS HLA typing protocol. We also investigated haplotype and allele frequencies of class I (HLA-A, -B, -C) and class II (HLA-DRB1, -DQB1 and -DPB1) alleles. Results: The results demonstrate the accuracy of this protocol, eliminating almost all ambiguities, providing a reasonable read length of 180, 76% mappability and 1267 depth of coverage on average for all 6 HLA loci. We found that the most frequent alleles for class I are HLA-A*02:01:01 (27,5%), B*51:01:01 (16,5%), C*07:01:01 (16,5%) and class II – DRB1*11:04:01 (14,5%), DQB1*03:01:01 (26,9%) and DPB1*04:01:01 (33,2%) which corresponds with other investigations of the research team on HLA diversity in the Bulgarian population.
Conclusion: The main advantages of GenDx NGS HLA typing protocol are the shorter time for DNA library preparation and the shorter sequencing time. Phasing ambiguities are also liminated, which is a signifi cant advantage in the clinical environment. The presented data show the suitability of this NGS protocol for clinical practice, especially in HLA typing of donors from Bone Marrow Donors registries.
References
Shiina T, Hosomichi K, Inoko H, Kulski JK. The HLA genomic loci map: Expression, interaction, diversity and disease. J Hum Genet, 2009, 54 (1), 15-39.
Janse van Rensburg WJ, de Kock A, Bester C, Kloppers JF. HLA and disease: Missing clinical data on laboratory request forms – a missed opportunity. South African Med J, 2021, 111 (1), 4.
Kennedy AE, Ozbek U, Dorak MT. What has GWAS done for HLA and disease associations? Int J Immunogenet, 2017, 44 (5), 195-211.
Edgerly CH, Weimer ET. The past, present, and future of HLA typing in transplantation. Methods Mol Biol, 2018, 1802, 1-10.
Mahdi BM. A glow of HLA typing in organ transplantation. Clin Transl Med, 2013, 2 (6), 1-5.
Bravo-Egana V, Sanders H, Chitnis N. New challenges, new opportunities: Next generation sequencing and its place in the advancement of HLA typing. Hum Immunol, 2021, 82 (7), 478-87.
Lind C, Ferriola D, Mackiewicz K, et al. Next-generation sequencing: The solution for high-resolution, unambiguous human leukocyte antigen typing. Hum Immunol, 2010, 71 (10), 1033-42.
Duke JL, Lind C, Mackiewicz K, et al. Determining performance characteristics of an NGS-based HLA typing method for clinical applications. HLA, 2016, 87 (3), 141-52.
De Santis D, Dinauer D, Duke J, et al. 16th IHIW: Review of HLA typing by NGS. Int J Immunogenet, 2013, 40 (1), 72-6.
Osoegawa K, Montero-Martín G, Mallempati KC, et al. Challenges for the standardized reporting of NGS HLA genotyping: Surveying gaps between clinical and research laboratories. Hum Immunol, 2021, 82 (11), 820-8.
Excoffi er L. Arlequin suite ver 3.5: A new series of programs to perform population genetics analyses under Linux and Windows. Mol Ecol Res, 2010, 10, 564-567.
RStudio Team. RStudio: Integrated Development Environment for R. RStudio, PBC, Boston, MA, 2021, http://www.rstudio.com/.
Klasberg S, Surendranath V, Lange V, Schöfl G. Bioinformatics Strategies, Challenges, and Opportunities for Next Generation Sequencing-Based HLA Genotyping. Transfus Med Hemotherapy, 2019, 46 (5), 312-24.
Brown NK, Merkens H, Rozemuller EH, et al. Reduced PCRgenerated errors from a hybrid capture-based NGS assay for HLA typing. Hum Immunol, 2021, 82 (4), 296-301.
Naumova Е, Ivanova М. Main tissue compatibility complex – facts, hypotheses, application in medicine. Sofi a, Litse, 2006, 13-26.
Zlatev A, Ivanova M, Michailova S, et al. Bulgarian bone marrow donors registry – Past and future directions. Cell Tissue Bank, 2008, 9 (4), 347-51.
Ivanova M, Rozemuller E, Tyufekchiev N, et al. HLA polymorphism in Bulgarians defi ned by high-resolution typing methods in comparison with other populations. Tissue Antigens, 2002, 60 (6), 496-504.
Gonzalez-Galarza FF, McCabe A, Santos EJM, et al. (2020) Allele frequency net database (AFND) 2020 update: Goldstandard data classifi cation, open access genotype data and new query tools. Nucleic Acids Res, 48 (D1), 783-8.
Downloads
Published
Issue
Section
License
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
You are free to share, copy and redistribute the material in any medium or format under these terms.
Journal Acta Medica Bulgarica 
